Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer
Clinical trial NCT02306954 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02306954
- Sponsor
- Providence Health & Services
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2020-09-15
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.